A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementiaShifu Xiao, Raoli He, Ying Peng et al.|Alzheimer s Research & Therapy|2021Cited by 200
RIP3 induces ischemic neuronal DNA degradation and programmed necrosis in rat via AIFYang Xu, Benyan Luo|Scientific Reports|2016Cited by 70
Crosstalk Between the Gut Microbiota and the Brain: An Update on Neuroimaging FindingsPing Liu, Benyan Luo|Frontiers in Neurology|2019Cited by 68
Depression Affects Intrinsic Brain Activity in Patients With Mild Cognitive ImpairmentYang Yu, Benyan Luo, Ziqi Li et al.|Frontiers in Neuroscience|2019Cited by 63
Loss of mitochondrial protein CHCHD10 in skeletal muscle causes neuromuscular junction impairmentYatao Xiao, Chengyong Shen, Jianmin Zhang et al.|Human Molecular Genetics|2019Cited by 48